# Koichi Nakanishi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/koichi-nakanishi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,664 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 53 |
| i10-index | 172 |
| Last Known Institution | University of the Ryukyus |
| OpenAlex ID | https://openalex.org/A5033754308 |
| ORCID iD | 0000-0001-8681-9129 |
| Works | 366 |

## Researcher papers

Showing 12 of 13.

- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/rituximab-for-childhood-onset-complicated-frequently-relapsing-nephrotic/)
- [IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome](https://scholariq.org/papers/ipna-clinical-practice-recommendations-for-the-diagnosis-and-management-of/)
- [Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group](https://scholariq.org/papers/alport-syndrome-a-unified-classification-of-genetic-disorders-of-collagen-iv-345/)
- [IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome](https://scholariq.org/papers/ipna-clinical-practice-recommendations-for-the-diagnosis-and-management-of-2/)
- [Achievements of KEKB](https://scholariq.org/papers/achievements-of-kekb/)
- [A review of clinical characteristics and genetic backgrounds in Alport syndrome](https://scholariq.org/papers/a-review-of-clinical-characteristics-and-genetic-backgrounds-in-alport-syndrome/)
- [Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor](https://scholariq.org/papers/treatment-of-polycystic-kidney-disease-with-a-novel-tyrosine-kinase-inhibitor/)
- [Organoids from Nephrotic Disease-Derived iPSCs Identify Impaired NEPHRIN Localization and Slit Diaphragm Formation in Kidney Podocytes](https://scholariq.org/papers/organoids-from-nephrotic-disease-derived-ipscs-identify-impaired-nephrin/)
- [Steroid Treatment for Severe Childhood IgA Nephropathy](https://scholariq.org/papers/steroid-treatment-for-severe-childhood-iga-nephropathy/)
- [Evidence-based clinical practice guidelines for polycystic kidney disease 2014](https://scholariq.org/papers/evidence-based-clinical-practice-guidelines-for-polycystic-kidney-disease-2014/)
- [A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020](https://scholariq.org/papers/a-digest-from-evidence-based-clinical-practice-guideline-for-polycystic-kidney/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Cell Adhesion Molecules Research](https://scholariq.org/topics/cell-adhesion-molecules-research/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [University of the Ryukyus](https://scholariq.org/institutions/university-of-the-ryukyus/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.